Delivery Order SPE2DB25D3108-SPE2DB25FPDQE
- Not listed
- The Defense Logistics Agency awarded a $1,041.42 delivery order to AmerisourceBergen Drug Corp for Repatha 140 mg/mL SureClick auto-injectors, with an ultimate completion date of July 30, 2025. This is a firm fixed price, non-set-aside contract with performance at AmerisourceBergen's Conshohocken, Pennsylvania facility. The delivery order is issued under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999.99 billion prime vendor agreement running...
- The Defense Logistics Agency awarded a $20,056.39 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Repatha 140 mg/ml SureClick auto-injector pens. The contract, which was not set-aside and competitively awarded, is scheduled for completion by August 18, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order is issued under the company's larger Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency has awarded a delivery order valued at $37,819.00 to AmerisourceBergen Drug Corp for the supply of Repatha 140 mg/ml SureClick auto-injector medication. This competitively awarded, firm fixed-price contract was issued on August 14, 2025, with an ultimate completion date of August 15, 2025, and will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The award represents a child order under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency has awarded a delivery order valued at $9,104.70 to AmerisourceBergen Drug Corp for the supply of Repatha 140 mg/mL SureClick auto-injectors, with an ultimate completion date of July 29, 2025. This competitively awarded, firm fixed-price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The primary contractor,...
- The Defense Logistics Agency awarded a delivery order valued at $2,603.55 to AmerisourceBergen Drug Corp for Repatha 140 mg/ml SureClick auto-injectors, with performance completed by August 13, 2025. This non-set-aside contract reflects a firm fixed-price delivery order issued under competitive procedures. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement, particularly...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $28,266.97 to AmerisourceBergen Drug Corp for the supply of Repatha 140 mg/mL SureClick auto-injectors. This firm fixed price, competitively awarded delivery order was executed on August 19, 2025, with an ultimate completion date of August 20, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a critical pharmaceutical supply for federal military and...
- The Defense Logistics Agency awarded a delivery order valued at $4,219.09 to AmerisourceBergen Drug Corp for Repatha 140 mg/mL SureClick auto-injectors. This competitive, firm fixed-price delivery order was issued on August 19, 2025, with an ultimate completion date of August 20, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop...
- The Defense Logistics Agency awarded a $4,165.68 delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for Repatha 140 mg/ml SureClick auto-injectors. The contract represents a firm fixed price delivery under a non-competitive set-aside arrangement and is scheduled for completion by July 21, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement and holds a substantial $999.999 billion...
- The Defense Logistics Agency awarded a delivery order valued at $2,270.22 to AmerisourceBergen Drug Corp for Repatha 140 mg/mL SureClick auto-injectors, with an ultimate completion date of August 20, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger prime Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December...
- The Defense Logistics Agency awarded a delivery order valued at $2,082.84 to AmerisourceBergen Drug Corp for Repatha 140 mg/mL SureClick auto-injectors, with an ultimate completion date of August 13, 2025. This non-set-aside, firm fixed price delivery order was competitively awarded and represents a single transaction under the company's larger pharmaceutical supply agreements with DLA. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a major pharmaceutical...
- SPE2DB25D3108Indefinite Delivery Contract
- SPE2DB25D3108-SPE2DB25FPDQEDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $4,104.50 to AmerisourceBergen Drug Corp for Repatha 140 mg/mL SureClick auto-injectors. The award, made on August 13, 2025, with an ultimate completion date of August 14, 2025, is a firm fixed price delivery order with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal medical procurement needs across military and veteran healthcare systems. This delivery order is issued under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99 billion comprehensive global pharmaceutical support vehicle valued through December 2026 that enables supply of medications and medical commodities to support military healthcare programs worldwide. Repatha is a PCSK9 inhibitor used for managing high cholesterol in patients with cardiovascular disease, representing a specialized pharmaceutical product within the Defense Logistics Agency's broader medical supply chain. AmerisourceBergen Drug Corp's extensive federal contract portfolio demonstrates its established capability to fulfill competitively awarded pharmaceutical delivery orders through open competition, with contract values ranging from minimal amounts to substantial orders exceeding $45,000. The firm's role as a prime vendor under the DLA's Pharmaceutical Prime Vendor Global Program reflects its strategic importance in providing critical medications and medical supplies across multiple therapeutic domains to support Defense Health Agency operations and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.1k | 8/13/25 |